Skip to content

Insider · CIK 0001653877

Regina E Groves

director

Files at ATRC (AtriCure, Inc.), FLGT (Fulgent Genetics, Inc.). First filing Aug 8, 2025, latest Sep 14, 2026.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 2
$0 bought, $378k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

ATRC: AtriCure, Inc.

ATRCOct 9, 2026 · close 55.81

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
42Moderate
ATRCsell 2
AtriCure, Inc.
$288k
5,313 shares
-13%-
39Weak
ATRCsell 3
AtriCure, Inc.
$90k
2,452 shares
-7%+36% from low-14% from high

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 11, 2026ATRC
AtriCure, Inc.
SOpen-market sale
Common Stock
-5,313$54.22$288k34,54628 d ago
Aug 6, 2025ATRC
AtriCure, Inc.
SOpen-market sale
Common Stock
-2,452$36.82$90k33,715Aug 8, 2025
May 19, 2025ATRC
AtriCure, Inc.
AGrant or award
Common Stock
+5,401$0.00$036,167May 21, 2025
May 15, 2025FLGT
Fulgent Genetics, Inc.
AGrant or award
Common Stock
+8,982$0.00$016,982May 19, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Regina E Groves: insider trades and track record | InsiderTell